Related Experiment Video
Updated: Apr 4, 2026

Isolation of Mouse Respiratory Epithelial Cells and Exposure to Experimental Cigarette Smoke at Air Liquid Interface
Published on: February 21, 2011
Prenatal Particulate Matter/Tobacco Smoke Increases Infants' Respiratory Infections: COCOA Study
Song I Yang1, Byoung Ju Kim2, So Yeon Lee1
1Department of Pediatrics, Hallym Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea.
Insights
Prenatal exposure to indoor fine particulate matter (PM₂.₅) and environmental tobacco smoke (ETS) increases infant susceptibility to lower respiratory tract infections (LRTIs). Genetic factors can modify these effects, highlighting the impact of early-life environmental exposures.
Area of Science:
- Environmental Health
- Pediatric Respiratory Medicine
- Genetic Epidemiology
Background:
- Infant respiratory tract infections (RTIs) pose a significant health burden.
- Indoor air pollutants, including fine particulate matter (PM₂.₅) and environmental tobacco smoke (ETS), are common exposures during pregnancy and infancy.
- The impact of these exposures on RTI susceptibility and potential genetic modifications requires further investigation.
Purpose of the Study:
- To assess the association between prenatal exposure to indoor PM₂.₅ and ETS and infant susceptibility to RTIs.
- To compare the effects of prenatal versus postnatal exposure to these pollutants.
- To determine if genetic polymorphisms modify the relationship between environmental exposures and RTI risk.
Main Methods:
- A cohort of 307 infants was studied.
- Indoor PM₂.₅ and ETS levels were measured during pregnancy and infancy.
- Genotyping for Nrf2, GSTP1, and GSTM1, along with genome-wide methylation analysis, was performed.
Main Results:
- Prenatal PM₂.₅ exposure significantly increased the risk of lower RTIs (LRTIs) in infancy (aOR=2.11).
- Combined prenatal exposure to PM₂.₅ and ETS showed a strong association with increased LRTIs (aOR=6.56), an effect not observed with postnatal exposure.
- Specific genotypes (Nrf2 GG, GSTM1 null, GSTP1 AG/GG) amplified the LRTIs risk associated with combined prenatal exposure to PM₂.₅ and ETS.
Conclusions:
- Prenatal exposure to both indoor PM₂.₅ and ETS may elevate infant susceptibility to LRTIs.
- Genetic variations in reactive oxygen species-related genes can modulate the impact of these prenatal exposures on LRTIs.
Purpose:
To investigate whether prenatal exposure to indoor fine particulate matter (PM₂.₅) and environmental tobacco smoke (ETS) affects susceptibility to respiratory tract infections (RTIs) in infancy, to compare their effects between prenatal and postnatal exposure, and to determine whether genetic factors modify these environmental effects.
Methods:
The study population consisted of 307 birth cohort infants. A diagnosis of RTIs was based on parental report of a physician's diagnosis. Indoor PM₂.₅ and ETS levels were measured during pregnancy and infancy. TaqMan was used for genotyping of nuclear factor erythroid 2-related factor (Nrf2) (rs6726395), glutathione-S-transferase-pi (GSTP) 1 (rs1695), and glutathione-S-transferase-mu (GSTM) 1. Microarrays were used for genome-wide methylation analysis.
Results:
Prenatal exposure to indoor PM₂.₅ increased the susceptibility of lower RTIs (LRTIs) in infancy (adjusted odds ratio [aOR]=2.11). In terms of combined exposure to both indoor PM₂.₅ and ETS, prenatal exposure to both pollutants increased susceptibility to LRTIs (aOR=6.56); however, this association was not found for postnatal exposure. The Nrf2 GG (aOR=23.69), GSTM1 null (aOR=8.18), and GSTP1 AG or GG (aOR=7.37) genotypes increased the combined LRTIs-promoting effects of prenatal exposure to the 2 indoor pollutants. Such effects of prenatal indoor PM₂.₅ and ETS exposure were not found for upper RTIs.
Conclusions:
Prenatal exposure to both indoor PM₂.₅ and ETS may increase susceptibility to LRTIs. This effect can be modified by polymorphisms in reactive oxygen species-related genes.
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Asthma-I: Introduction
Development of the Oral Microbiota

